The fact is: Unfortunately medical science still offers no non-surgical therapy that would be capable of removing the plaque or even causing a notable change to the symptoms at least.
That will probably surprise you. You may be one of the many patients who continue to have medications such as Potaba, tamoxifen, colchicine, vitamin E or other wonder drugs prescribed by their urologists or physicians for the ‘treatment’ of Peyronie’s disease.
This is very unfortunate and shows the serious influence of the pharmaceutical industry.
We do not wish to bore you with our own opinion of the medications listed above at this point, but rather will quote from a certified continuing medical education that was already published by Springer in the medical journal Der Urologe (The Urologist) on 14 January 2006.
On the subject of the most commonly used non-surgical methods for treating Peyronie’s disease, it states:
1. Potassium para-aminobenzoic acid (Potaba): ‘showed no notable effect’
2. Vitamin E: ‘there is no scientific evidence that therapy for Peyronie’s disease using vitamin E is sensible’
3. Tamoxifen: ‘use for Peyronie’s disease is not sensible’
4. Colchicine: ‘the use of colchicine for Peyronie’s disease is not sensible’
5. Verapamil: ‘no effect on Peyronie’s disease could be proven’
On the subject of shockwave therapy it was also stated: ‘it cannot be recommended’
On the subject of radiation therapy: ‘this therapy does not appear to be sensible for Peyronie’s disease’
It is frightening that few urologists or physicians seem to care, despite these results and despite the fact that they were already published in 2006 – in a medical journal for urology, at that. Nearly all patients who contact us still report that they were prescribed either Potaba or vitamin E by their physician – without any noticeable effect. Some of them suffered from significant side effects during the use of these medications.
Please excuse our blunt language in this section.
Everyday urology is unfortunately very conservative when it comes to diseases to the penis itself. Many patients report that they had the impression that their urologist was uncomfortable discussing this disease, did not provide extensive answers to questions or did not even want to really listen. In fact this unfortunately still seems to be the case. Even the topics of visual changes to the penis and erectile disorders due to diseases of the penis continue to be taboo in Germany.
They are not discussed in social situations either, not even between close friends. This can be seen in the fact that Peyronie’s disease was forgotten to be listed at all in the medical accounting system at that time.
The German medical journal Deutsches Ärzteblatt consequently published an article entitled ‘Induratio Penis Plastica – eine verschwiegene Erkrankung’ (‘Induratio Penis Plastica – a Concealed Disease’) in February 2007. Accordingly, the therapy is mostly poor as well.
We are annoyed by the fact that patients are driven to take almost completely ineffective medication and to squander valuable time due to a lack of information or due to erroneous information. For more on this, see the previous section entitled ‘Course of the disease‘.
We are also annoyed by the fact that we often have to ‘apologise’ for the fact that standard urologists know so little about Peyronie’s disease, even though this has nothing to do with us.
Dear patient, please ask the urologist who is treating you about this. We have been specialised in the treatment of Peyronie’s disease for years and know precisely what it involves.